Analysis of bulk and virus-specific CD8+ T cells reveals advanced differentiation of CD8+ T cells in patients with common variable immunodeficiency

Clinical Immunology

Volumn 141, Issue 2, 2011, Pages 177-186

  Kuntz, Martin ^a   Goldacker, Sigune ^a   Blum, Hubert E ^a   Pircher, Hanspeter ^b   Stampf, Susanne ^a   Peter, Hans Hartmut ^a   Thimme, Robert ^a   Warnatz, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Anti viral CD8+ T cell response; ; Common Variable Immunodeficiency; ; Cytomegalovirus; ; Epstein Barr virus; ; Influenza virus; ; Lymphadenopathy

Indexed keywords

HLA A2 ANTIGEN;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; GRANULOMATOSIS; HUMAN; HUMAN CELL; IMMUNOCOMPROMISED PATIENT; LYMPHADENOPATHY; LYMPHOCYTE DIFFERENTIATION; MALE; PRIORITY JOURNAL; SPLENOMEGALY; VIRUS IMMUNITY;

ADULT; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; COMMON VARIABLE IMMUNODEFICIENCY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GRANULOMA; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOPHENOTYPING; LYMPHATIC DISEASES; MALE; MIDDLE AGED; OLIGOPEPTIDES; ORTHOMYXOVIRIDAE; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTE SUBSETS; VIRAL MATRIX PROTEINS; VIREMIA; YOUNG ADULT;

EID: 80054845611     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.07.006     Document Type: Article

References (31)

1. Giovannetti A., Pierdominici M., Mazzetta F., Marziali M., Renzi C., Mileo A.M., De Felice M., Mora B., Esposito A., Carello R., Pizzuti A., Paggi M.G., Paganelli R., Malorni W., Aiuti F. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J. Immunol. 2007, 178:3932-3943.
2. Serrano D., Becker K., Cunningham-Rundles C., Mayer L. Characterization of the T cell receptor repertoire in patients with common variable immunodeficiency: oligoclonal expansion of CD8(+) T cells. Clin. Immunol. 2000, 97:248-258.
3. Viallard J.F., Blanco P., Andre M., Etienne G., Liferman F., Neau D., Vidal E., Moreau J.F., Pellegrin J.L. CD8+HLA-DR+T lymphocytes are increased in common variable immunodeficiency patients with impaired memory B-cell differentiation. Clin. Immunol. 2006, 119:51-58.
4. Werwitzke S., Drescher B., Schmidt R.E., Witte T. CD8+ T cell populations in common variable immunodeficiency. Immunobiology 2000, 202:168-171.
5. Lanio N., Sarmiento E., Gallego A., Carbone J. Immunophenotypic profile of T cells in common variable immunodeficiency: is there an association with different clinical findings?. Allergol. Immunopathol. (Madr) 2009, 37:14-20.
6. Raeiszadeh M., Kopycinski J., Paston S.J., Diss T., Lowdell M., Hardy G.A., Hislop A.D., Workman S., Dodi A., Emery V., Webster A.D. The T cell response to persistent herpes virus infections in common variable immunodeficiency. Clin. Exp. Immunol. 2006, 146:234-242.
7. Haveman L.M., Scherrenburg J., Maarschalk-Ellerbroek L.J., Hoek P.D., Schuurman R., de Jager W., Ellerbroek P.M., Prakken B.J., van Baarle D., van Montfrans J.M. T cell response to viral antigens in adults and children with common variable immunodeficiency and specific antibody deficiency. Clin. Exp. Immunol. 2010, 161:108-117.
8. Appay V., van Lier R.A., Sallusto F., Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008, 73:975-983.
9. Campbell J.D., Stinson M.J., Simons F.E., Rector E.S., HayGlass K.T. In vivo stability of human chemokine and chemokine receptor expression. Hum. Immunol. 2001, 62:668-678.
10. Kaech S.M., Tan J.T., Wherry E.J., Konieczny B.T., Surh C.D., Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 2003, 4:1191-1198.
11. Chadburn A., Inghirami G., Knowles D.M. The kinetics and temporal expression of T-cell activation-associated antigens CD15 (LeuM1), CD30 (Ki-1), EMA, and CD11c (LeuM5) by benign activated T cells. Hematol. Pathol. 1992, 6:193-202.
12. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.
13. Brenchley J.M., Karandikar N.J., Betts M.R., Ambrozak D.R., Hill B.J., Crotty L.E., Casazza J.P., Kuruppu J., Migueles S.A., Connors M., Roederer M., Douek D.C., Koup R.A. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003, 101:2711-2720.
14. Thimme R., Appay V., Koschella M., Panther E., Roth E., Hislop A.D., Rickinson A.B., Rowland-Jones S.L., Blum H.E., Pircher H. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation. J. Virol. 2005, 79:12112-12116.
15. Voehringer D., Koschella M., Pircher H. Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1). Blood 2002, 100:3698-3702.
16. Thimme R., Oldach D., Chang K.M., Steiger C., Ray S.C., Chisari F.V. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 2001, 194:1395-1406.
17. Marcolino I., Przybylski G.K., Koschella M., Schmidt C.A., Voehringer D., Schlesier M., Pircher H. Frequent expression of the natural killer cell receptor KLRG1 in human cord blood T cells: correlation with replicative history. Eur. J. Immunol. 2004, 34:2672-2680.
18. Holm A.M., Sivertsen E.A., Tunheim S.H., Haug T., Bjerkeli V., Yndestad A., Aukrust P., Froland S.S. Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells. Clin. Exp. Immunol. 2004, 138:278-289.
19. Vlkova M., Thon V., Sarfyova M., Blaha L., Svobodnik A., Lokaj J., Litzman J. Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients. Clin. Exp. Immunol. 2006, 143:373-379.
20. Joshi N.S., Kaech S.M. Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation. J. Immunol. 2008, 180:1309-1315.
21. Wiesel M., Walton S., Richter K., Oxenius A. Virus-specific CD8 T cells: activation, differentiation and memory formation. APMIS 2009, 117:356-381.
22. Aukrust P., Lien E., Kristoffersen A.K., Muller F., Haug C.J., Espevik T., Froland S.S. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency-possible immunologic and clinical consequences. Blood 1996, 87:674-681.
23. Martinez-Pomar N., Raga S., Ferrer J., Pons J., Munoz-Saa I., Julia M.R., de Gracia J., Matamoros N. Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene. Clin. Exp. Immunol. 2006, 144:233-238.
24. Bucks C.M., Norton J.A., Boesteanu A.C., Mueller Y.M., Katsikis P.D. Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion. J. Immunol. 2009, 182:6697-6708.
25. Warnatz K., Denz A., Drager R., Braun M., Groth C., Wolff-Vorbeck G., Eibel H., Schlesier M., Peter H.H. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002, 99:1544-1551.
26. Wehr C., Kivioja T., Schmitt C., Ferry B., Witte T., Eren E., Vlkova M., Hernandez M., Detkova D., Bos P.R., Poerksen G., von Bernuth H., Baumann U., Goldacker S., Gutenberger S., Schlesier M., Bergeron-van der Cruyssen F., Le Garff M., Debre P., Jacobs R., Jones J., Bateman E., Litzman J., van Hagen P.M., Plebani A., Schmidt R.E., Thon V., Quinti I., Espanol T., Webster A.D., Chapel H., Vihinen M., Oksenhendler E., Peter H.H., Warnatz K. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008, 111:77-85.
27. Wright J.J., Wagner D.K., Blaese R.M., Hagengruber C., Waldmann T.A., Fleisher T.A. Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. Blood 1990, 76:2046-2051.
28. Bachmann M.F., Hunziker L., Zinkernagel R.M., Storni T., Kopf M. Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key. Eur. J. Immunol. 2004, 34:317-326.
29. Wheat W.H., Cool C.D., Morimoto Y., Rai P.R., Kirkpatrick C.H., Lindenbaum B.A., Bates C.A., Ellison M.C., Serls A.E., Brown K.K., Routes J.M. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J. Exp. Med. 2005, 202:479-484.
30. Chidrawar S., Khan N., Wei W., McLarnon A., Smith N., Nayak L., Moss P. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin. Exp. Immunol. 2009, 155:423-432.
31. Koch S., Larbi A., Ozcelik D., Solana R., Gouttefangeas C., Attig S., Wikby A., Strindhall J., Franceschi C., Pawelec G. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann. N. Y. Acad. Sci. 2007, 1114:23-35.